Given the role of eNOS-derived NO in modulating APP processing and in maintaining cerebrovascular function [12,13,16], we postulated that partial eNOS deficiency might exacerbate amyloid plaque load and other AD-like pathology in the hippocampus of APP/PS1 mice. This evidence concerns the gene NOS3 and Alzheimer disease.